01213nam0 22002891i 450 UON0052028120231205105541.69188-7394-047-120231120d2005 |0itac50 baitaIT|||| |||||ˆL'‰immunità dello spettatoreinterpretazioni del consumo e teoria socialeLuisa AielloRomaCooper2005319 p.21 cm001UON005202822001 Archeologia della contemporaneitàcollana diretta da Alberto Abruzzese210 RomaCooper[19--]-ConsumoAspetti socio-culturaliUONC060984FIITRomaUONL000004306.3Sociologiaeconomica / Istituzioni economiche / Antropologia economica21AIELLOLuisaUONV293228144169CooperUONV254701650ITSOL20250620RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00520281SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI F. Signore3 D 818 SI 47653 5 Immunità dello spettatore735745UNIOR03552nam 22006735 450 991030009680332120251117071625.01-4471-5472-X10.1007/978-1-4471-5472-3(CKB)3710000000073724(EBL)1592860(SSID)ssj0001067244(PQKBManifestationID)11612776(PQKBTitleCode)TC0001067244(PQKBWorkID)11097044(PQKB)10554283(MiAaPQ)EBC1592860(DE-He213)978-1-4471-5472-3(PPN)176096949(EXLCZ)99371000000007372420131121d2014 u| 0engur|n|---|||||txtccrCardiac Drugs in Pregnancy /edited by Karen Sliwa, John Anthony1st ed. 2014.London :Springer London :Imprint: Springer,2014.1 online resource (141 p.)Current Cardiovascular TherapyDescription based upon print version of record.1-4471-5471-1 Introduction -- General principles and guidelines -- Management of Hypertension -- Management of Heart Failure -- Management of  coronary artery disease & Arrhythmia -- Anticoagulation in Pregnancy -- Obstetric drugs in management if Cardiovascular disease -- Pregnancy anaesthesia in patients with cardiovascular disease.In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and  discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy.Current Cardiovascular TherapyCardiologyObstetricsMaternal and child health servicesChemotherapyCardiologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H33037Obstetrics/Perinatology/Midwiferyhttps://scigraph.springernature.com/ontologies/product-market-codes/H26014Maternal and Child Healthhttps://scigraph.springernature.com/ontologies/product-market-codes/H27025Pharmacotherapyhttps://scigraph.springernature.com/ontologies/product-market-codes/H69000Cardiology.Obstetrics.Maternal and child health services.Chemotherapy.Cardiology.Obstetrics/Perinatology/Midwifery.Maternal and Child Health.Pharmacotherapy.616.1061Sliwa Karenedthttp://id.loc.gov/vocabulary/relators/edtAnthony John(Professor of obstetrics and gynecology)edthttp://id.loc.gov/vocabulary/relators/edtBOOK9910300096803321Cardiac Drugs in Pregnancy1522055UNINA